[{"AccountsPayableCurrent_0_Q1_USD":10337000.0,"ContractWithCustomerLiability_0_Q1_USD":34400000.0,"ContractWithCustomerAssetNet_0_Q1_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-8352000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":46694000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":1249000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_1_Q1_shares":0.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":556000.0,"OtherDeferredCostsNet_0_Q1_USD":2519000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":5399000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":1249000.0,"OtherLiabilitiesCurrent_0_Q1_USD":544000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-5000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-1569000.0,"ShortTermInvestments_0_Q1_USD":73339000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_0_Q1_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":3.46,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":84000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":323000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-9139000.0,"InvestmentIncomeInterest_1_Q1_USD":510000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":1396000.0,"CommonStockValueOutstanding_0_Q1_USD":3000.0,"OperatingLeaseExpense_1_Q1_USD":300000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":34408000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-9060000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":10700000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q1_pure":0.6174,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q1_pure":0.6413,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":19161000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":27283000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":27242000.0,"OtherNoncashIncomeExpense_1_Q1_USD":64000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.072,"OperatingLeaseRightOfUseAsset_0_Q1_USD":1529000.0,"OperatingLeasePayments_1_Q1_USD":400000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":556000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1107000.0,"OperatingLeaseLiability_0_Q1_USD":1663000.0,"NumberOfReportableSegments_1_Q1_Segment":1.0,"MarketableSecuritiesRealizedGainLoss_1_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":1039000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":403000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":319000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":1761000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":3919000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":-83000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":729000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1_Q1_USD":3000.0,"DividendsCommonStock_1_Q1_USD":0.0,"DebtLongtermAndShorttermCombinedAmount_0_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q1_pure":0.0166,"ProvisionForDoubtfulAccounts_1_Q1_USD":0.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":31345029.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-8643000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-35000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":323000.0,"LiabilitiesCurrent_0_Q1_USD":52120000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":151878000.0,"Liabilities_0_Q1_USD":52676000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-178000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":2208000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":2385000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":30000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-9109000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.29,"CostsAndExpenses_1_Q1_USD":28786000.0,"CostOfRevenue_1_Q1_USD":15122000.0,"CommonStockSharesOutstanding_0_Q1_shares":31530443.0,"CommonStockSharesIssued_0_Q1_shares":31530443.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":46694000.0,"AssetsCurrent_0_Q1_USD":135416000.0,"Assets_0_Q1_USD":151878000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":6062009.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":73000.0,"AccruedIncomeTaxesCurrent_0_Q1_USD":57000.0,"AccountsReceivableNetCurrent_0_Q1_USD":5508000.0,"NetIncomeLoss_1_Q1_USD":-9139000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":248854000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":76000.0,"ProfitLoss_1_Q1_USD":-9139000.0,"OtherAssetsNoncurrent_0_Q1_USD":1531000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q1_USD":10500000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":8000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":10200000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":323000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"ShareBasedCompensation_1_Q1_USD":1249000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":7274000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":6390000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"OperatingIncomeLoss_1_Q1_USD":-9625000.0,"InterestExpense_1_Q1_USD":2000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommitmentsAndContingencies_0_Q1_USD":null,"AllowanceForDoubtfulAccountsReceivable_0_Q1_USD":100000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":268000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":31345029.0,"StockholdersEquity_0_Q1_USD":99202000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-149728000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":13402000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":3437000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q1_pure":0.0058,"Ticker":"PSNL","CIK":"1527753","name":"PERSONALIS, INC.","OfficialName":"Personalis Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"307257592.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]